Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques

Mutations in presenilin-1 (PS-1) account for the majority of familial Alzheimer's disease (AD). While increasing Abeta42 is one mechanism whereby PS-1 mutations are thought to exert their pathogenic effect, little is known about the role of tau in PS-1 AD. This study compares staining (AT8 and...

Full description

Bibliographic Details
Main Authors: Claire E Shepherd, Gillian C Gregory, James C Vickers, William S Brooks, John B.J Kwok, Peter R Schofield, Jillian J Kril, Glenda M Halliday
Format: Article
Language:English
Published: Elsevier 2004-02-01
Series:Neurobiology of Disease
Subjects:
Tau
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996103002134
id doaj-04390dca3802434183f5546b3ac6577e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Claire E Shepherd
Gillian C Gregory
James C Vickers
William S Brooks
John B.J Kwok
Peter R Schofield
Jillian J Kril
Glenda M Halliday
spellingShingle Claire E Shepherd
Gillian C Gregory
James C Vickers
William S Brooks
John B.J Kwok
Peter R Schofield
Jillian J Kril
Glenda M Halliday
Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
Neurobiology of Disease
Alzheimer's disease
Presenilin
Tau
Phosphorylation
Cotton wool plaques
author_facet Claire E Shepherd
Gillian C Gregory
James C Vickers
William S Brooks
John B.J Kwok
Peter R Schofield
Jillian J Kril
Glenda M Halliday
author_sort Claire E Shepherd
title Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
title_short Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
title_full Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
title_fullStr Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
title_full_unstemmed Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
title_sort positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2004-02-01
description Mutations in presenilin-1 (PS-1) account for the majority of familial Alzheimer's disease (AD). While increasing Abeta42 is one mechanism whereby PS-1 mutations are thought to exert their pathogenic effect, little is known about the role of tau in PS-1 AD. This study compares staining (AT8 and tau-2), morphology and quantity of tau-immunoreactive cortical plaques in six PS-1 and five sporadic AD cases. The densities of tau-positive plaques differentiated PS-1 from sporadic AD cases. All PS-1 cases demonstrated a greater than 6-fold increase in tau-2-positive plaques. In PS-1 cases with mutations in exons 5 and 6, there was an increase in classical AD plaques containing hyperphosphorylated tau (AT8- and tau 2-positive). However, cases with exon 8 and 9 mutations had numerous cotton wool plaques containing nonhyperphosphorylated tau (tau-2-positive, AT8-negative). These findings suggest that PS-1 mutations increase tau deposition while mutation-specific cellular responses determine phosphorylation events and may influence cell death mechanisms.
topic Alzheimer's disease
Presenilin
Tau
Phosphorylation
Cotton wool plaques
url http://www.sciencedirect.com/science/article/pii/S0969996103002134
work_keys_str_mv AT claireeshepherd positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT gilliancgregory positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT jamescvickers positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT williamsbrooks positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT johnbjkwok positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT peterrschofield positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT jillianjkril positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
AT glendamhalliday positionaleffectsofpresenilin1mutationsontauphosphorylationincorticalplaques
_version_ 1724212085285453824
spelling doaj-04390dca3802434183f5546b3ac6577e2021-03-20T04:49:01ZengElsevierNeurobiology of Disease1095-953X2004-02-01151115119Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaquesClaire E Shepherd0Gillian C Gregory1James C Vickers2William S Brooks3John B.J Kwok4Peter R Schofield5Jillian J Kril6Glenda M Halliday7Prince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaPrince of Wales Medical Research Institute, Randwick, Sydney 2031, Australia; Centre for Education and Research on Ageing, The University of Sydney, Concord Hospital, Concord 2139, Australia; The University of New South Wales, Sydney 2052, Australia; Discipline of Pathology, University of Tasmania, Hobart, Tasmania 7000, Australia; Garvan Institute of Medical Research, Sydney 2010, AustraliaMutations in presenilin-1 (PS-1) account for the majority of familial Alzheimer's disease (AD). While increasing Abeta42 is one mechanism whereby PS-1 mutations are thought to exert their pathogenic effect, little is known about the role of tau in PS-1 AD. This study compares staining (AT8 and tau-2), morphology and quantity of tau-immunoreactive cortical plaques in six PS-1 and five sporadic AD cases. The densities of tau-positive plaques differentiated PS-1 from sporadic AD cases. All PS-1 cases demonstrated a greater than 6-fold increase in tau-2-positive plaques. In PS-1 cases with mutations in exons 5 and 6, there was an increase in classical AD plaques containing hyperphosphorylated tau (AT8- and tau 2-positive). However, cases with exon 8 and 9 mutations had numerous cotton wool plaques containing nonhyperphosphorylated tau (tau-2-positive, AT8-negative). These findings suggest that PS-1 mutations increase tau deposition while mutation-specific cellular responses determine phosphorylation events and may influence cell death mechanisms.http://www.sciencedirect.com/science/article/pii/S0969996103002134Alzheimer's diseasePresenilinTauPhosphorylationCotton wool plaques